老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

25.18
+0.61002.48%
盘前：25.650.4700+1.87%07:18 EDT
成交量：194.40万
成交额：4,894.08万
市值：24.76亿
市盈率：-4.32
高：25.45
开：24.75
低：24.71
收：24.57
52周最高：42.37
52周最低：18.29
股本：9,831.72万
流通股本：9,449.35万
量比：1.15
换手率：2.06%
股息：- -
股息率：- -
每股收益(TTM):-5.8316
每股收益(LYR):-5.8316
净资产收益率：-608.47%
总资产收益率：-22.03%
市净率：-30.95
市盈率(LYR):-4.32

数据加载中...

总览公司新闻资讯公告
2020/09/02

重要事件披露

8-K - Current report
2020/07/31

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/31

重要事件披露

8-K - Current report
2020/06/30

重要事件披露

8-K - Current report
2020/06/30

重要事件披露

8-K - Current report
2020/06/18

重要事件披露

8-K - Current report
2020/05/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/15

重要事件披露

8-K - Current report
2020/05/13

重要事件披露

8-K - Current report
2020/05/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/01

重要事件披露

Current report, items 3.02, 8.01, and 9.01
2020/03/06

重要事件披露

8-K - Current report
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

员工持股计划

Securities to be offered to employees in employee benefit plans
更多